You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Ascend Laboratories, LLCFDAMed source confidence · 80%Jun 22, 2026, 6:17 PM UTC · 15d ago
Ascend Laboratories, LLC — FDA Class II (D-0556-2026)
Case File
Ascend Laboratories, LLC is recalling 15,696 bottles of a human prescription drug due to failed dissolution specifications. This recall is classified as a Class II recall. The affected products include NDCs 67877-499, 67877-500, 67877-501, and 67877-502.
•Ascend Laboratories, LLC is recalling 15,696 bottles of a human prescription drug.
•The recall is due to failed dissolution specifications.
•Affected NDCs include 67877-499, 67877-500, 67877-501, and 67877-502.
•Patients should check their medicine cabinets for these products.
Why This Matters
Patients using these recalled drugs may experience ineffective treatment due to the failed specifications. They should stop using the product and consult their healthcare provider.